Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study ; volume:10 ; number:1 ; day:3 ; month:5 ; year:2024 ; pages:1-9 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (3.5.2024), 1-9, 12.2024
- Creator
-
Matarazzo, Michele
Pérez-Soriano, Alexandra
Vafai, Nasim
Shahinfard, Elham
Cheng, Kevin Ju-Chieh
McKenzie, Jessamyn
Neilson, Nicole
Miao, Qing
Schaffer, Paul
Shinotoh, Hitoshi
Kordower, Jeffrey H.
Sossi, Vesna
Stoessl, A. Jon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00708-z
- URN
-
urn:nbn:de:101:1-2407142127579.151811116537
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Matarazzo, Michele
- Pérez-Soriano, Alexandra
- Vafai, Nasim
- Shahinfard, Elham
- Cheng, Kevin Ju-Chieh
- McKenzie, Jessamyn
- Neilson, Nicole
- Miao, Qing
- Schaffer, Paul
- Shinotoh, Hitoshi
- Kordower, Jeffrey H.
- Sossi, Vesna
- Stoessl, A. Jon
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
The heterogeneity of Parkinson’s disease
Sleep disorders in Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
The heterogeneity of Parkinson’s disease
Sleep disorders in Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
The heterogeneity of Parkinson’s disease